Julian Bonte-Friedheim - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Julian Bonte-Friedheim's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Julian Bonte-Friedheim
Verified
Head Writer, The Perspective
Tel Aviv
Beats
Crypto , Blockchain
gaming, politics
Content
By Julian Bonte-Friedheim| theperspective.com@ *Updated 2021Taking a semester or year to study abroad is an experience that is presented to most college students as a great learning experience. However, universities should also educate their students about potential drawbacks, which can be numerous. Whether the upsides outweigh the downsides is what we’re about to explore in the following arguments.
By Julian Bonte-Friedheim| theperspective.com@ *Updated 2021The United States and soccer, the rest of the world’s favorite sport, have always had a complicated relationship. Long seen as a children’s game, professional soccer has never reached the popularity that professional sports like basketball or football enjoy. Renewed efforts have been made to grow American interest in it, most notably David Beckham’s and Zlatan Ibrahimovic’s transfers to LA Galaxy in 2007 and 2018, respectively.
By Julian Bonte-Friedheim| theperspective.com@ *Updated 2021Taking a semester or year to study abroad is an experience that is presented to most college students as a great learning experience. However, universities should also educate their students about potential drawbacks, which can be numerous. Whether the upsides outweigh the downsides is what we’re about to explore in the following arguments.
Company Info
The Perspective
The Perspective is a clinical-stage radiopharmaceutical company focused on developing innovative cancer treatments using targeted alpha-particle therapies. Established in February 2023, the company utilizes the alpha-emitting isotope Pb-212 to deliver localized radiation directly to cancer cells, minimizing damage to surrounding healthy tissue. The company specializes in radiopharmaceutical therapies that combine Pb-212 with tumor-specific targeting peptides. They also offer theranostic platforms that use Pb-203 radiotracers for imaging, allowing physicians to confirm tumor characteristics before treatment. This approach helps in selecting suitable patients and reducing toxicity. Perspective Therapeutics collaborates with leading medical institutions and pharmaceutical companies to advance clinical trials and enhance their treatment pipeline, aiming to improve patient outcomes through effective and targeted therapies.
Founded: 2017